Cargando…
Molecular findings in maxillofacial bone tumours and its diagnostic value
According to the WHO, mesenchymal tumours of the maxillofacial bones are subdivided in benign and malignant maxillofacial bone and cartilage tumours, fibro-osseous and osteochondromatous lesions as well as giant cell lesions and bone cysts. The histology always needs to be evaluated considering also...
Autores principales: | Cleven, Arjen H.G., Schreuder, Willem H., Groen, Eline, Kroon, Herman M., Baumhoer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968989/ https://www.ncbi.nlm.nih.gov/pubmed/31838586 http://dx.doi.org/10.1007/s00428-019-02726-2 |
Ejemplares similares
-
Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours
por: Cleven, Arjen H. G., et al.
Publicado: (2022) -
Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst
por: Ong, Sheena L.M., et al.
Publicado: (2021) -
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma
por: Lam, Suk Wai, et al.
Publicado: (2019) -
Treatment of Progressive Cherubism during the Second Dental Transitional Phase with Calcitonin
por: Meijer, Ethan, et al.
Publicado: (2023) -
NTRK fusions are extremely rare in bone tumours
por: Lam, Suk Wai, et al.
Publicado: (2021)